Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- AVANT Appeals Delisting Notification From NASDAQ
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today that on January 8, 2008 it received a letter from The NASDAQ Stock Market indicating that AVANT had failed to regain compliance with the Nasdaq Capital Market's minimum bid price requirement of $1.00 per share for continued listing of AVANT's...
- Research articles 2008-01-09
- Hot Stock Watch: HLUN is on the Move! April 11, 2006.
- M2 PRESSWIRE-11 April 2006-Wall Street News Alert: Hot Stock Watch: HLUN is on the Move! April 11, 2006C1994-2006 M2 COMMUNICATIONS LTD RDATE:11042006 Weston, FLA. - Wall Street News Alert's "stocks to watch" this morning are: Healtheuniverse Inc. (OTC: HLUN), StemCells, Inc....
- Research articles 2006-04-11
- Columbia, S.C., Picks Local Firm for Hotel Project.
- By C. Grant Jackson, The State, Columbia, S.C. Knight Ridder/Tribune Business News Dec. 12--The city of Columbia is going into the hotel business. City Council agreed Wednesday that a group led by Edens & Avant Real Estate Services should build a...
- Research articles 2002-12-12
- Pass the alka seltzer - The Antenna - Brief Article
- THE EDA FEEDING FRENZY IS AFFECTING THE DIGESTION PROCESS. Cadence has swallowed three companies and counting and Synopsys/Avant! is silently squirming while the FTC takes its sweet time. You'd think that would give companies such as Monterey and Magma time to build up their customer bases. However, in Magma's...
- Research articles 2002-05-13
- Double Digit Losses Over 60% Following News.
- VANCOUVER, BRITISH COLUMBIA, FEBRUARY 21, 2002 Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was Avant Immunotherapeutics (NASDAQ: AVAN) today announcing that TP10, its lead complement inhibitor, failed to meet the...
- Research articles 2002-02-26
- Double Digit Losses Over 60% Following News.
- VANCOUVER, BRITISH COLUMBIA, FEBRUARY 20, 2002 Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was Avant Immunotherapeutics (NASDAQ: AVAN) today announcing that TP10, its lead complement inhibitor, failed to meet the...
- Research articles 2002-02-20
Additional Resources
- PFIZER Inc. and Avant Immunotherapeutics.(agreement to develop animal vaccines)(Brief Article)
- PFIZER Inc. and Avant Immunotherapeutics have formed an agreement to develop animal vaccines. Pfizer is paying $2.5 million in up-front licensing ... PFIZER Inc. and Avant Immunotherapeutics have formed an agreement to develop animal vaccines. Pfizer is paying $2.5 million in up-front licensing...
- Research articles 2000-12-04
- Edens & Avant Names Will Ponder Vice President, Investments
- COLUMBIA, S.C., June 24 /PRNewswire/ -- Edens & Avant announced today the promotion of Will Ponder to Vice President, Investments, responsible for Edens & Avant's Southeast portfolio encompassing 40 properties. In this role, Ponder will proactively execute strategic plans for the overall Southeast portfolio as well...
- Research articles 2009-06-24
- New Congressional Defense Bill Supports Development and Purchase of Vaccines to Meet the Nation's Public Health Threats; AVANT Expects to Participate in the Development of New Vaccine Technologies to Meet These Threats
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that the new Congressional defense bill, which passed today and is expected to be signed by President Bush, will provide over $3 billion for the development and purchase of vaccines, antivirals and necessary medical equipment as well as for critical...
- Research articles 2005-12-22
- New Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYOND INC
- MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for AVANT...
- Research articles 2008-06-02
- Research and Markets: AVANT Immunotherapeutics Inc - Deals and Alliances Report Provides an Unbiased, Accurate, Independent Approach to Company Analysis, Whether for Partnering or Investment Purposes
- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49832) has announced the addition of "AVANT Immunotherapeutics Inc - Deals and Alliances Report" to their offering.
- Research articles 2007-02-06
- TheSUBWAY.com Announces Investment Opinion: Closing Above The Low!
- Keep an eye on CBCom, Inc. (OTCBB: CBCI) The Company just releases huge news. CBCI could be a huge winner in the short term. Other stock market standouts include Synopsys Inc. (Nasdaq: SNPS), down 2% on 4 million shares ahead of shareholder vote on Avant Deal, Microchip Technology Inc....
- Research articles 1970-01-01
- MaverickTrader.Com Announces Investment Opinion; FREE Ratings on Synopsys, United Micro, Avant, Manugistics, and Apple
- Business Editors
- Research articles 2001-12-04
- Insanely Great Marketing
- Apple's obsession with its own image makes great products look even more glamorous. 1. A Clear Sense of the Customer Apple has positioned itself as the...
- Articles 2009-08-10
- << Previous
- page 1 of 1
- Next >>
